Clearside Biomedical Inc

NASDAQ:CLSD   12:07:25 PM EDT
5.05
-0.33 (-6.13%)
Products

Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For Xiper (Triamcinolone Acetonide Suprachoroidal Injectable Suspension)

Published: 06/02/2021 11:22 GMT
Clearside Biomedical Inc (CLSD) - Bausch Health and Clearside Biomedical Announce U.S. FDA Filing Acceptance for Xipere™ (triamcinolone Acetonide Suprachoroidal Injectable Suspension).
Bausch Health Companies Inc - PDUFA Action Date is October 30, 2021.